Duopeng An
Impact in
- Pharmaceutical Science top 10%
- Advancements in Transdermal Drug Delivery
-
- Ionic liquids properties and applications
Papers in
-
- Peroxisome Proliferator-Activated Receptors 1
- Oncology 4
- Cancer Immunotherapy and Biomarkers 2
- Co-authors
- Meiqing Feng (3 shared papers)Jiyang Li (3 shared papers)Shanshan Jiang (3 shared papers)Quangang Zhu (2 shared papers)Ye Li (1 shared paper)Xin Wang (1 shared paper)Hongchuan Liu (3 shared papers)Qian Wang (1 shared paper)
- Journals
- Applied Microbiology and Biotechnology (2 papers)Phytomedicine (1 paper)Biological and Pharmaceutical Bulletin (1 paper)International Immunopharmacology (1 paper)Journal of drug targeting (1 paper)
- Partner nations
- ChinaUnited StatesSouth Korea
In The Last Decade
Duopeng An
11 papers receiving 334 citations
Peers
Comparison fields: 5 of 76
- Pharmaceutical Science 40
- Catalysis 32
- Toxicology 9
- Cancer Research 33
- Biomaterials 29
Countries citing papers authored by Duopeng An
This map shows the geographic impact of Duopeng An's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Duopeng An with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Duopeng An more than expected).
Fields of papers citing papers by Duopeng An
This network shows the impact of papers produced by Duopeng An. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Duopeng An. The network helps show where Duopeng An may publish in the future.
Co-authors
The 25 scholars most cited alongside Duopeng An, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 86 | |
| 2 | 2019 | 76 | |
| 3 | 2022 | 47 | |
| 4 | 2016 | 40 | |
| 5 | 2021 | 23 | |
| 6 | 2020 | 19 | |
| 7 | 2021 | 17 | |
| 8 | 2019 | 13 | |
| 9 | 2016 | 9 | |
| 10 | 2023 | 4 | |
| 11 | 2017 | 3 |
About Duopeng An
Duopeng An is a scholar working on Molecular Biology, Oncology, Pharmacology, Immunology and Infectious Diseases, having authored 11 papers that have together received 337 indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (2 papers), Fungal Biology and Applications (2 papers), Cancer Immunotherapy and Biomarkers (2 papers), Cancer Mechanisms and Therapy (1 paper), Peroxisome Proliferator-Activated Receptors (1 paper), Ferroptosis and cancer prognosis (1 paper), Plant Pathogens and Fungal Diseases (1 paper) and Plant-Microbe Interactions and Immunity (1 paper). The work is most often cited by research in Pharmaceutical Science (40 citations), Catalysis (32 citations), Toxicology (9 citations), Cancer Research (33 citations) and Biomaterials (29 citations). Duopeng An has collaborated with scholars based in China, United States and South Korea. Frequent co-authors include Meiqing Feng, Jiyang Li, Shanshan Jiang, Quangang Zhu, Meiqing Feng, Ye Li, Xin Wang, Hongchuan Liu, Qian Wang and Xiaohan Guo. Their work appears in journals such as Applied Microbiology and Biotechnology, Phytomedicine, Biological and Pharmaceutical Bulletin, International Immunopharmacology and Journal of drug targeting.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.